HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors
- PMID: 20163922
- PMCID: PMC4447191
- DOI: 10.1016/j.drugalcdep.2009.12.028
HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors
Abstract
Objectives: As no single HIV prevention program has eliminated HIV transmission, there is growing interest in the effectiveness of "combined" prevention programming. To compare HIV infection among persons injecting in the initial programs environment (IPE) in New York City (self-initiated risk reduction, methadone, education/outreach, and HIV testing) to HIV infection among persons injecting in a combined programs environment (CPE) (above programs plus large-scale syringe exchange). To identify potential behavioral mechanisms through which combined programs are effective.
Methods: Subjects were recruited from the Beth Israel drug detoxification program. A risk behavior questionnaire was administered and HIV testing conducted. Subjects who injected only between 1984 and 1994 (IPE) were compared to subjects who injected only between 1995 and 2008 (CPE).
Results: 261 IPE subjects and 1153 CPE subjects were recruited. HIV infection was significantly lower among the CPE subjects compared to IPE subjects: prevalence 6% versus 21%, estimated incidence 0.3/100 person-years versus 4/100 person-years (both p<0.001). The percentage of subjects at risk of acquiring HIV through receptive syringe sharing was similar across CPE and IPE subjects (30% versus 33%). The percentage of subjects at risk of transmitting HIV through injection-related behaviors (who were both HIV seropositive and reported passing on used needles/syringes), was much lower among the CPE subjects than among the IPE subjects (1% versus 10%, p<0.001).
Conclusions: Combined prevention programs can greatly reduce HIV transmission. Reducing distributive sharing by HIV seropositive injecting drug users (IDUs) may be a critical component in reducing HIV transmission in high seroprevalence settings.
Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.
Conflict of interest statement
All authors declare that they have no conflicts of interest.
Figures
Similar articles
-
"Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):158-66. doi: 10.1097/00126334-200402010-00010. J Acquir Immune Defic Syndr. 2004. PMID: 14722449
-
HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.MMWR Surveill Summ. 2014 Jul 4;63(6):1-51. MMWR Surveill Summ. 2014. PMID: 24990587
-
A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.Indian J Public Health. 1995 Jul-Sep;39(3):86-92. Indian J Public Health. 1995. PMID: 8690497
-
[Intravenous drug use and the spread of HIV; an international perspective].Ned Tijdschr Geneeskd. 2013;157(21):A5690. Ned Tijdschr Geneeskd. 2013. PMID: 23693006 Review. Dutch.
-
HIV infection among intravenous drug users: epidemiology and risk reduction.AIDS. 1987 Jul;1(2):67-76. AIDS. 1987. PMID: 3130084 Review.
Cited by
-
Is the severity of the Great Recession's aftershocks correlated with changes in access to the combined prevention environment among people who inject drugs?Int J Drug Policy. 2021 Sep;95:103264. doi: 10.1016/j.drugpo.2021.103264. Epub 2021 May 11. Int J Drug Policy. 2021. PMID: 33990058 Free PMC article.
-
Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013.Drug Alcohol Depend. 2015 Jul 1;152:194-200. doi: 10.1016/j.drugalcdep.2015.03.039. Epub 2015 Apr 13. Drug Alcohol Depend. 2015. PMID: 25891230 Free PMC article.
-
Increasing HIV prevention and care for injecting drug users.Lancet. 2010 Mar 20;375(9719):961-3. doi: 10.1016/S0140-6736(10)60314-5. Epub 2010 Feb 26. Lancet. 2010. PMID: 20189639 Free PMC article. No abstract available.
-
Understanding the effects of different HIV transmission models in individual-based microsimulation of HIV epidemic dynamics in people who inject drugs.Epidemiol Infect. 2016 Jun;144(8):1683-700. doi: 10.1017/S0950268815003180. Epub 2016 Jan 12. Epidemiol Infect. 2016. PMID: 26753627 Free PMC article.
-
Cost-Effectiveness of the 'One4All' HIV Linkage Intervention in Guangxi Zhuang Autonomous Region, China.PLoS One. 2016 Nov 28;11(11):e0167308. doi: 10.1371/journal.pone.0167308. eCollection 2016. PLoS One. 2016. PMID: 27893864 Free PMC article. Clinical Trial.
References
-
- Cooper D, Pantaleo G, Mastro T, Abdool-Karim Q, editors. Current Opinion in HIV and AIDS Journal. 2009;4(4):1–345. - PubMed
-
- Committee on the Prevention of HIV Infection among Injecting Drug Users in High Risk Countries. Preventing HIV Infection among Injecting Drug Users in High Risk Countries: an Assessment of the Evidence. Institute of Medicine, Washington; 2006.
-
- Crepaz N, Lyles C, Wolitski R, Passin W, Rama S, Herbst J, Purcell D, Malow R, Stall R. Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS. 2006;20:143–157. - PubMed
-
- Des Jarlais D. Can HIV be eliminated among injecting drug users?. Proceedings of the 2009 National HIV Prevention Conference; Atlanta, GA. 2009.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous